| Chirocaine (levobupivacaine) / Purdue, AbbVie |
ChiCTR-TRC-14004644: The effect of epidural dexmedetomidine on the intestinal peristalsis function after colorectal operation |
|
|
| Completed | 1 | 75 | | none ;add some dose of morphine to levobupivacaine ;add some dose of morphine to levobupivacaine | Second affiliated Hospital, Harbin Medical University; Level of the institution：, self-finance | Gastrointestinal diseases | | | | |
NCT03824314: Effect of Adding Midazolam Versus Fentanyl to Intrathecal Levobupivacaine in Patients Undergoing Caesarean Section |
|
|
| Completed | 1 | 80 | RoW | Midazolam, Fentanyl | Mohamed Abdelrady Mohamed | Cesarean Section Complications | 01/20 | 02/20 | | |
NCT04315454: Aalgesic Efficacy of Erector -Spinae Technique With Levobupvicaine in Patients Undergoing Upper Abdominal Cancer Surgery |
|
|
| Unknown status | 1 | 30 | RoW | Levobupivacaine | South Egypt Cancer Institute | Erector Spinae Block Analgesia | 12/20 | 04/21 | | |
| Unknown status | 1 | 70 | NA | Bupivacaine-fentanyl, levobupivacaine-fentanyl | Assiut University | Labor Pain | 03/21 | 03/21 | | |
NCT04498351: Magnesium Sulfate in Combination With Dexmedetomidine As Adjuvants to Levobupivacaine |
|
|
| Completed | 1 | 130 | RoW | Control Test, Dexmedetomidine, Dexmedetomidine and magnesium sulphate, magnesium sulphate | Cairo University | Spermatic Cord Block | 09/21 | 10/21 | | |
NCT05559437: Ultrasound-guided Ilioinguinal/Iliohypogastric Nerve Block |
|
|
| Completed | 1 | 60 | RoW | Levo-bupivacaine 0.25 | Egymedicalpedia | Inguinal Hernia Repair, Pain, Postoperative | 04/23 | 04/23 | | |
NCT05600296: Ultrasound-guided Ilioinguinal/Iliohypogastric Nerve Block Compared to the Combined Therapy With Spermatic Cord Block |
|
|
| Completed | 1 | 46 | RoW | Levobupivacaine, Ilioinguinal/iliohypogastric nerve block (IINB), IINB+ Spermatic cord block | Egymedicalpedia | Hernia, Inguinal | 05/23 | 05/23 | | |
ChiCTR2200064437: Phase I clinical study on safety, tolerance and pharmacokinetics of LL10 in healthy volunteers |
|
|
| Completed | 1 | 179 | | Subcutaneous injection: 4mL of Levobupivacaine hydrochloride injection at concentration of 0.325% and 0.5%; Subcutaneous injection: 4mL of 0.9% sodium chloride injection; Subcutaneous injection: 4mL of 0.13%/0.033% levobupivacaine and 2-hydroxyethyl lidocaine aminium bromide injection (LL10); Subcutaneous injection: 4mL of 0.25%/0.065% LL10; Subcutaneous injection: 4mL of 0.44%/0.113% LL10; Subcutaneous injection: 4mL of 0.63%/0.163% LL10; Subcutaneous injection: 4mL of 0.88%/0.227% LL10; Subcutaneous injection: 4mL of 1.07%/0.276% LL10; Subcutaneous injection: 4mL of 1.26%/0.325% LL10; Subcutaneous injection: 0.9% sodium chloride injection (10, 15, 20, 25, 30, 35mL, one participant for each volume ); Subcutaneous injection: 10mL of C% LL-10 (C, the concentration of LL10 in the Ib study, was chosen according to the findings of the Ia study); Subcutaneous injection: 15mL of C% LL10; Subcutaneous injection: 20mL of C% LL10; Subcutaneous injection: 25mL of C% LL10; Subcutaneous injection: 30mL of C% LL10; Subcutaneous injection: 35mL of C% LL10; Femoral nerve block:20mL of 0.325% Levobupivacaine hydrochloride injection; Femoral nerve block: 20mL of 0.9% sodium chloride injection; Femoral nerve block: 20mL of 0.13%/0.033% LL10; Femoral nerve block: 20mL of 0.25%/0.065% LL10; Femoral nerve block: 20mL of 0.5%/0.129% LL10; Femoral nerve block: 20mL of 0.75%/0.193% LL10; Femoral nerve block: 20mL of 1.05%/0.271% LL10; Femoral nerve block: 20mL of 1.26%/0.325% LL10; Transversus abdominis plane block: 30mL of 0.325% Levobupivacaine hydrochloride injection; Transversus abdominis plane block: 30mL of 0.9% sodium chloride injection; Transversus abdominis plane block: 25mL of 1.26%/0.325% LL10; Transversus abdominis plane block: 30mL of 1.26%/0.325% LL10; Transversus abdominis plane block: 35mL of 1.26%/0.325% LL10; Transversus abdominis plane block: 40mL of 1.26%/0.325% LL10; Transversus abdominis plane block: 45mL of 1.26%/0.325% LL10; Transversus abdominis plane block: 50mL of 1.26%/0.325% LL10; Transversus abdominis plane block: 55mL of 1.26%/0.325% LL10; Transversus abdominis plane block: 60mL of 1.26%/0.325% LL10 | West China Hospital, Sichuan University; West China Hospital of Sichuan University, Shangdong New Times Pharmaceutical Co., Ltd. | N/A | | | | |
